MENU
OCGN
AS OF
Feb 4, 04:02 PM (EDT)
Price
$1.43
Change
-$0.08 (-5.30%)
Capitalization
494.25M
51 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
OCGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ocugen (OCGN) Ownership - Who owns Ocugen?

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
494.25M
P/E Ratio
N/A
Total Cash
32.57M
Projected Growth
N/A
Total Debt
32.96M
Revenue
5.37M
Risk (Beta)
3.48
Dividend Yield
N/A
Total Cash/Share
0.10
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

OCGN
Capitalization
494M
P/E Ratio
N/A
Risk (Beta)
3.48
Dividend Yield
N/A
Total Cash
32.6M
Total Cash/Share
0.10
Total Debt
33M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
5.37M
ROE
N/A
Book Value
3.53M
P/B Ratio
140.85
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.13M
Current Ratio
1.85
Current Revenue Per Employee
18442.10
Dividends Per Share - Security
N/A
EBITDA
-57.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-107.12
Shares Held By Institutions
108M
Shares Outstanding - Current
327M
Total Liabilities
54.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
11.852
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
OCGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OCGN showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for OCGN
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of therapies for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com